{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T20:17:44Z","timestamp":1790021864472,"version":"4.0.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["7224327"],"award-info":[{"award-number":["7224327"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.nmd.2023.07.007","type":"journal-article","created":{"date-parts":[[2023,7,30]],"date-time":"2023-07-30T09:51:47Z","timestamp":1690710707000},"page":"81-89","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["HyperCKemia: An early sign of childhood-onset neutral lipid storage disease with myopathy"],"prefix":"10.1016","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2520-2912","authenticated-orcid":false,"given":"Xiaona","family":"Fu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinying","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingbing","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenna","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaotun","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junlan","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.nmd.2023.07.007_bib0001","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/ng1951","article-title":"The gene encoding adipose triglyceride lipase (PNPLA2) is mutated in neutral lipid storage disease with myopathy","volume":"39","author":"Fischer","year":"2007","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.nmd.2023.07.007_bib0002","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s13023-017-0646-9","article-title":"Neutral lipid storage diseases: clinical\/genetic features and natural history in a large cohort of Italian patients","volume":"12","author":"Pennisi","year":"2017","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"10.1016\/j.nmd.2023.07.007_bib0003","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/s13023-019-1209-z","article-title":"Neutral lipid storage disease with myopathy in China: a large multicentric cohort study","volume":"14","author":"Zhang","year":"2019","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"10.1016\/j.nmd.2023.07.007_bib0004","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/ped4.12263","article-title":"Identification of potential pathogenic mutations in Chinese children with first branchial cleft anomalies detected by whole-exome sequencing","volume":"5","author":"Yang","year":"2021","journal-title":"Pediatr Investig"},{"issue":"6","key":"10.1016\/j.nmd.2023.07.007_bib0005","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/j.1468-1331.2010.03012.x","article-title":"EFNS guidelines on the diagnostic approach to pauci- or asymptomatic hyperCKemia","volume":"17","author":"Kyriakides","year":"2010","journal-title":"Eur J Neurol"},{"issue":"1","key":"10.1016\/j.nmd.2023.07.007_bib0006","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/mus.27448","article-title":"An integrated approach to the evaluation of patients with asymptomatic or minimally symptomatic hyperCKemia","volume":"65","author":"Gemelli","year":"2022","journal-title":"Muscle Nerve"},{"issue":"6","key":"10.1016\/j.nmd.2023.07.007_bib0007","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.nmd.2010.04.004","article-title":"Neutral lipid storage disease with subclinical myopathy due to a retrotransposal insertion in the PNPLA2 gene","volume":"20","author":"Akman","year":"2010","journal-title":"Neuromuscul Disord"},{"issue":"8","key":"10.1016\/j.nmd.2023.07.007_bib0008","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/ejhg.2012.256","article-title":"Symptomatic lipid storage in carriers for the PNPLA2 gene","volume":"21","author":"Janssen","year":"2013","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.nmd.2023.07.007_bib0009","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ijcard.2016.01.137","article-title":"Severe cardiomyopathy in a young patient with complete deficiency of adipose triglyceride lipase due to a novel mutation in PNPLA2 gene","volume":"207","author":"Pasanisi","year":"2016","journal-title":"Int J Cardiol"},{"issue":"1","key":"10.1016\/j.nmd.2023.07.007_bib0010","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.bbrc.2012.10.127","article-title":"Subclinical myopathy in a child with neutral lipid storage disease and mutations in the PNPLA2 gene","volume":"430","author":"Fiorillo","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"issue":"12","key":"10.1016\/j.nmd.2023.07.007_bib0011","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.nmd.2013.08.008","article-title":"PNPLA2 mutation: a paediatric case with early onset but indolent course","volume":"23","author":"Perrin","year":"2013","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"10.1016\/j.nmd.2023.07.007_bib0012","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s12881-018-0683-9","article-title":"Novel PNPLA2 gene mutation in a child causing neutral lipid storage disease with myopathy","volume":"19","author":"Zheng","year":"2018","journal-title":"BMC Med Genet"},{"issue":"1","key":"10.1016\/j.nmd.2023.07.007_bib0013","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.nmd.2020.11.007","article-title":"Early onset neutral lipid storage disease with myopathy presenting as congenital hypotonia and hepatomegaly","volume":"31","author":"Avila-Smirnow","year":"2021","journal-title":"Neuromuscul Disord"},{"issue":"3","key":"10.1016\/j.nmd.2023.07.007_bib0014","first-page":"559","article-title":"Neutral lipid storage disease with myopathy presenting asymmetrical muscle weakness: a case report","volume":"13","author":"Zhang","year":"2020","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.nmd.2023.07.007_bib0015","article-title":"Case report: PNPLA2 gene complex heterozygous mutation leading to neutral lipid storage disease with myopathy","volume":"14","author":"Shi","year":"2020","journal-title":"Front Integr Neurosci"},{"issue":"19","key":"10.1016\/j.nmd.2023.07.007_bib0016","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1097\/CM9.0000000000002004","article-title":"Late onset of neutral lipid storage disease due to a rare PNPLA2 mutation in a patient with myopathy and cardiomyopathy","volume":"135","author":"Tian","year":"2022","journal-title":"Chin Med J (Engl)"},{"issue":"1","key":"10.1016\/j.nmd.2023.07.007_bib0017","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.gendis.2019.07.006","article-title":"A novel PNPLA2 mutation causing total loss of RNA and protein expression in two NLSDM siblings with early onset but slowly progressive severe myopathy","volume":"8","author":"Tavian","year":"2021","journal-title":"Genes Dis"},{"issue":"9","key":"10.1016\/j.nmd.2023.07.007_bib0018","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1001\/archneurol.2011.2600","article-title":"A novel mutation in PNPLA2 leading to neutral lipid storage disease with myopathy","volume":"69","author":"Ash","year":"2012","journal-title":"Arch Neurol"},{"issue":"8","key":"10.1016\/j.nmd.2023.07.007_bib0019","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1212\/WNL.0000000000002999","article-title":"Clinical reasoning: A 33-year-old man with cardiomyopathy and myopathy","volume":"87","author":"Foster","year":"2016","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.nmd.2023.07.007_bib0020","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.nmd.2018.04.010","article-title":"Neutral lipid storage disease with myopathy: Further phenotypic characterization of a rare PNPLA2 variant","volume":"28","author":"Latimer","year":"2018","journal-title":"Neuromuscul Disord"},{"issue":"6","key":"10.1016\/j.nmd.2023.07.007_bib0021","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1002\/mus.20869","article-title":"Novel duplication mutation in the patatin domain of adipose triglyceride lipase (PNPLA2) in neutral lipid storage disease with severe myopathy","volume":"36","author":"Akiyama","year":"2007","journal-title":"Muscle Nerve"},{"issue":"8","key":"10.1016\/j.nmd.2023.07.007_bib0022","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.nmd.2008.06.382","article-title":"Distal lipid storage myopathy due to PNPLA2 mutation","volume":"18","author":"Ohkuma","year":"2008","journal-title":"Neuromuscul Disord"},{"issue":"7","key":"10.1016\/j.nmd.2023.07.007_bib0023","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.nmd.2014.04.001","article-title":"A novel mutation in PNPLA2 causes neutral lipid storage disease with myopathy and triglyceride deposit cardiomyovasculopathy: a case report and literature review","volume":"24","author":"Kaneko","year":"2014","journal-title":"Neuromuscul Disord"},{"issue":"11","key":"10.1016\/j.nmd.2023.07.007_bib0024","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1007\/s00415-011-6055-4","article-title":"The phenotypic spectrum of neutral lipid storage myopathy due to mutations in the PNPLA2 gene","volume":"258","author":"Reilich","year":"2011","journal-title":"J Neurol"},{"issue":"2","key":"10.1016\/j.nmd.2023.07.007_bib0025","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ymgme.2012.12.004","article-title":"Neutral lipid storage disease with myopathy: a whole-body nuclear MRI and metabolic study","volume":"108","author":"Laforet","year":"2013","journal-title":"Mol Genet Metab"},{"issue":"3","key":"10.1016\/j.nmd.2023.07.007_bib0026","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.bbrc.2008.10.081","article-title":"Novel mutations in the adipose triglyceride lipase gene causing neutral lipid storage disease with myopathy","volume":"377","author":"Campagna","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.nmd.2023.07.007_bib0027","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ijcard.2016.02.082","article-title":"Whole exome sequence analysis reveals a homozygous mutation in PNPLA2 as the cause of severe dilated cardiomyopathy secondary to neutral lipid storage disease","volume":"210","author":"Muggenthaler","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.nmd.2023.07.007_bib0028","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jocn.2018.10.046","article-title":"Neutral lipid storage disease with myopathy and dropped head syndrome. Report of a new variant susceptible of treatment with late diagnosis","volume":"58","author":"Garcia","year":"2018","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.nmd.2023.07.007_bib0029","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.clineuro.2018.03.001","article-title":"Patients with neutral lipid storage disease with myopathy (NLSDM) in Southwestern China","volume":"168","author":"Tan","year":"2018","journal-title":"Clin Neurol Neurosurg"},{"issue":"5","key":"10.1016\/j.nmd.2023.07.007_bib0030","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"issue":"12","key":"10.1016\/j.nmd.2023.07.007_bib0031","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/jhg.2016.94","article-title":"FKRP mutations, including a founder mutation, cause phenotype variability in Chinese patients with dystroglycanopathies","volume":"61","author":"Fu","year":"2016","journal-title":"J Hum Genet"},{"issue":"4","key":"10.1016\/j.nmd.2023.07.007_bib0032","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.55730\/1300-0144.5431","article-title":"The clinical, pathological, and genetic characteristics of lipid storage myopathy in northern China","volume":"52","author":"Han","year":"2022","journal-title":"Turk J Med Sci"},{"issue":"5","key":"10.1016\/j.nmd.2023.07.007_bib0033","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1161\/CIRCRESAHA.113.300944","article-title":"Effects of bezafibrate treatment in a patient and a carrier with mutations in the PNPLA2 gene, causing neutral lipid storage disease with myopathy","volume":"112","author":"van de Weijer","year":"2013","journal-title":"Circ Res"},{"issue":"1","key":"10.1016\/j.nmd.2023.07.007_bib0034","doi-asserted-by":"crossref","first-page":"72","DOI":"10.4274\/tjh.93798","article-title":"Chanarin-dorfman syndrome with multi-system involvement in two siblings","volume":"30","author":"Arslansoyu Camlar","year":"2013","journal-title":"Turk J Haematol"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896623001748?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896623001748?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:13:20Z","timestamp":1760775200000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896623001748"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":34,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S0960896623001748"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2023.07.007","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HyperCKemia: An early sign of childhood-onset neutral lipid storage disease with myopathy","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2023.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}